Optimal Extent of Lymphadenectomy for Intrahepatic Cholangiocarcinoma

Abstract

Introduction: The prognostic role and optimal extent of lymphadenectomy for intrahepatic cholangiocarcinoma (ICC) remain debated. Guidelines are inconsistent regarding the number of nodes that should be harvested. This review examines the relationship between lymph node yield, staging accuracy, and survival.

Methods: A systematic literature review identified studies examining lymphadenectomy in ICC. The primary outcome was the association between number of examined lymph nodes and overall survival. Secondary outcomes included the optimal cutoff for node positivity.

Results: Fifteen retrospective series (total over three thousand patients) were included. A minimum of six to seven lymph nodes was required to accurately stage node-negative disease. Node positivity occurred in thirty to forty percent of patients. Survival was significantly better in node-negative patients with adequate nodal harvest (≥ six nodes). Among node-positive patients, the lymph node ratio (positive/total) provided additional prognostic stratification.

Discussion: Incomplete lymphadenectomy leads to stage migration, potentially denying some patients adjuvant therapy. The region of dissection (hilar versus hepatoduodenal) is not standardized. The therapeutic role of lymphadenectomy is unclear, but accurate staging is essential for prognosis and trial entry.

Conclusions: A minimum lymph node yield of six should be achieved during surgery for intrahepatic cholangiocarcinoma to ensure accurate staging. Prospective studies are needed to define the therapeutic benefit.